Clinical & translational oncology

• 

  Año 2023, Vol. 25, Número 5 (May)

  • REVIEW ARTICLE

    • Understanding the role of Cripto-1 in cancer progression and therapeutic strategies

      Qingfang Zeng, Yuzhen Gao, Ying Zhou

      • Resumen

      págs. 1135-1144

      

    • Cancer secretome: finding out hidden messages in extracellular secretions

      Mrunali Padgaonkar, Saket Shendre, Prarthana Chatterjee, Satarupa Banerjee

      • Resumen

      págs. 1145-1155

      

    • CRISPR-Cas9-mediated gene therapy in lung cancer

      Hossein Kazemizadeh, Alireza Kashefizadeh

      • Resumen

      págs. 1156-1166

      

    • siRNA and targeted delivery systems in breast cancer therapy

      Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Maliheh Entezari, Seyed Hesamoddin Bidooki, Vahideh Javadian Ghaleh, Shamin Rezaei, Elahe Sadat Hejazi, Amirabbas Kakavand, Mitra Behroozaghdam, Abolfazl Movafagh, Afshin Taheriazam, Mehrdad Hashemi, Saeed Samarghandian

      • Resumen

      págs. 1167-1188

      

    • MicroRNA-452: a double-edged sword in multiple human cancers

      Fateme Karimi Dermani, Ishwaree Datta, S.G. Khoei

      • Resumen

      págs. 1189-1206

      

    • The multifaced role and therapeutic regulation of autophagy in ovarian cancer

      Fahimeh Nokhostin, Mahboobeh Azadehrah, Malihe Azadehrah

      • Resumen

      págs. 1207-1217

      

    • Brain metastasis in breast cancer: focus on genes and signaling pathways involved, blood–brain barrier and treatment strategies

      Y. Chhichholiya, Malayil Ruthuparna, Harini Velagaleti, Anjana Munshi

      • Resumen

      págs. 1218-1241

      

    • PARs in the inflammation-cancer transformation of CRC

      Jianyu Lv, Jinguo Liu, Guanqun Chao, Shuo Zhang

      • Resumen

      págs. 1242-1251

      

  • SPECIAL ARTICLE

    • New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

      Dolores Isla Casado, María Dolores Lozano, Luis Paz-Ares Rodríguez, Clara Salas Antón, Javier de Castro Carpeño, E. Conde Gallego, Enriqueta Felip Font, José Javier Gómez Román, María Pilar Garrido López, Ana Belen Enguita Valls

      • Resumen

      págs. 1252-1267

      

    • Hospital-based proton therapy implementation during the COVID pandemic: early clinical and research experience in a European academic institution

      Felipe A. Calvo Manuel, Jacobo Palma Delgado, Francisco Javier Serrano Andreu, Mauricio Cambeiro Vázquez, Rosa M. Meiriño Seoane, Santiago Martin, Juan Diego Azcona Armendáriz, Diego Pedrero, Borja Aguilar Redondo, José Miguel Delgado, Verónica Morán Velasco, Alberto Viñals Muñoz, José Pablo Cabello García, Elena Panizo Morgado, Álvaro Lassaletta Atienza, Carlota Gibert, Lidia Sancho Rodríguez, Jose María Fernández de Miguel, Beatriz Alvarez de Sierra, Andres Alcázar, Víctor M. Suárez Vega, Alberto Alonso Burgos, G. Gallardo Madueño, José Javier Aristu Mendioroz

      • Resumen

      págs. 1268-1276

      

  • RESEARCH ARTICLE

    • C-Fos-activated circRPPH1 contributes to glioma stemness

      G. Xu, Jianqiang Qu, Ming Zhang, Qian Wang

      • Resumen

      págs. 1277-1286

      

    • Radiation pneumonitis in relation to pulmonary function, dosimetric factors, TGFβ1 expression, and quality of life in breast cancer patients receiving post-operative radiotherapy: a prospective 6-month follow-up study

      Z. Ozgen, Oya Orun, B. M. Atasoy, Pinar Mega Tiber, Esra Akdeniz, Canan Cimsit, Emel Eryuksel, Sait Karakurt

      • Resumen

      págs. 1287-1296

      

    • 125I brachytherapy: a useful treatment to control painful osteoblastic bone metastases

      Yiming Liu, Chengzhi Zhang, Kaihao Xu, Kunpeng Wu, Xinwei Han, Dechao Jiao

      • Resumen

      págs. 1297-1306

      

    • Risk and prognosis of secondary breast cancer after radiation therapy for non-Hodgkin lymphoma: a massive population-based analysis

      Xiaoyan Lv, Pengpeng Yue, Fuling Zhou

      • Resumen

      págs. 1307-1314

      

    • Correlation analysis of lipid metabolism genes with the immune microenvironment in gastric cancer and the construction of a novel gene signature

      Yaqi Li, Xu Chen, Ruijuan Zhang, Menglin Chen, Junyu Shen, Jian Wu, Jichao Yu, Qingmin Sun

      • Resumen

      págs. 1315-1331

      

    • TIPE1 inhibits the growth of Ewing’s sarcoma cells by suppressing Wnt/β-catenin signaling

      Zhichao Wang, Libin Sun, Shuaiyin Liu, Haitao Jiang

      • Resumen

      págs. 1332-1339

      

    • High expression of CETN2 is associated with platinum resistance and poor prognosis in epithelial ovarian cancer

      Pei-yuan Qiu, Xi-han Deng, Li Li

      • Resumen

      págs. 1340-1352

      

    • Immune infiltration could predict the efficacy of short-term radiotherapy in patients with cervical cancer

      Zhiqiang Sun, Xue Liu, Jing Song, Hui Liu, Shuyu Zhang, Judong Luo

      • Resumen

      págs. 1353-1367

      

    • Predicted cardiac and second cancer risks for patients undergoing VMAT for mediastinal Hodgkin lymphoma

      Orla A. Houlihan, Georgios Ntentas, David J. Cutter, Patricia Daly, Charles Gillham, Orla McArdle, Frances K. Duane

      • Resumen

      págs. 1368-1377

      

    • Fear stress promotes glioma progression through inhibition of ferroptosis by enhancing FSP1 stability

      Chaojie Bu, Sen Hu, Jinliang Yu, Nianxuan Li, Jianjun Gu, Zhiyuan Sheng, Zhaoyue Yan, Xingyao Bu

      • Resumen

      págs. 1378-1388

      

    • Adipocytes secretome from normal and tumor breast favor breast cancer invasion by metabolic reprogramming

      Maurice Zaoui, Mehdi Morel, Lila Louadj, Nathalie Ferrand, Antonin Lamazière, Catherine Uzan, Geoffroy Canlorbe, Michael Atlan, Michèle Sabbah

      • Resumen

      págs. 1389-1401

      

    • PIK3R2 predicts poor outcomes for patients with melanoma and contributes to the malignant progression via PI3K/AKT/NF-κB axis

      Jianguo Wang, Shizhong Cai, Qianwei Xiong, Deyu Weng, Qian Wang, Zhourui Ma

      • Resumen

      págs. 1402-1412

      

    • Construction of prediction model for prognosis of uterine corpus endometrial carcinoma based on pyroptosis gene

      Chunyan Zhang, Jie Bai, Yu Yang, Xiaojuan Wang, Wanqiu Liu, Shujuan Hou, Zhongwei Ai, Qingling Xia, Lei Shao

      • Resumen

      págs. 1413-1424

      

    • ADAM12 promotes gemcitabine resistance by activating EGFR signaling pathway and induces EMT in bladder cancer

      Runchang Wang, Dongyang Gao, Chaohu Chen, Guangrui Fan, Hui Cheng, Yan Tao, Jianzhong Lu, Junqiang Tian, Yuhan Wang, Zhiping Wang

      • Resumen

      págs. 1425-1435

      

    • Prognostic role and clinical significance of tumor-infiltrating lymphocyte (TIL) and programmed death ligand 1 (PD-L1) expression in gastric cancer: a systematic review and meta-analysis

      Juan Ren, Qinglian He, Hui Yin, Li Zheng, Lan Li, Xiaoling Wu

      • Resumen

      págs. 1436-1445

      

    • Measurable residual disease study through three different methods can anticipate relapse and guide pre-emptive therapy in childhood acute myeloid leukemia

      E. Ramos Elbal, José Luis Fuster Soler, José Antonio Campillo Marquina, A. Galera Miñarro, M. Bermúdez Cortés, E. Llinares Riestra, Irene Jiménez, Mercedes Plaza Fornieles, Helios Martínez Banaclocha, José Antonio Galian Megias, M. Blanquer Blanquer, Maria Victoria Martinez Sanchez, Manuel Muro Amador, Alfredo Minguela Puras

      • Resumen

      págs. 1446-1454

      

    • Maintenance of angiogenesis inhibition with aflibercept after progression to bevacizumab in metastatic colorectal cancer: real life study in the Valencian community

      Mireia Gil Raga, I. Paredero, Rebeca Chulvi Veiga, Marcos Melian Sosa, María José Safont, Paula Llor Rodríguez, M. Teresa Taberner Bonastre, Jorge Aparicio Urtasun, Laura Palomar Abad, Isabel Busquier Hernandez

      • Resumen

      págs. 1455-1462

      

    • Axillary staging and management of cN + breast cancer patients treated with neoadjuvant chemotherapy: results of a survey among breast cancer surgeons in Spain

      Paula Munoz, Sara Corral Moreno, Fernando Martínez Regueira, Alejandro Paz Yañez, Vicente Muñoz Madero, Antonio Mena Mateos, Jacobo Cabañas Montero, Sonia Rivas Fidalgo

      • Resumen

      págs. 1463-1471

      

    • HNF4G stimulates the development of pancreatic cancer by promoting IGF2BP2 transcription

      Jian Zhan, Qian Zhang, Xu Tong, Xu Liu, Chunbo Zhao

      • Resumen

      págs. 1472-1481

      

    • A multi-center cross-sectional investigation of the diagnosis and treatment of breast cancer with synchronous ipsilateral supraclavicular lymph node metastases based on the CSBrs-009

      Xiang Ai, Peng Sun, Minghao Wang, Peng Tang, Jinping Liu, Jun Jiang

      • Resumen

      págs. 1482-1487